All News

Estroven can help reduce menopause symptoms such as hot flashes and night sweats, and helps to manage daily stress.

Mesalamine (Apriso) is a locally acting aminosalicylate indicated to treat and prevent flare-ups of ulcerative colitis.

Many people who experience a grand mal seizure never have another one and don't need treatment.

The results of a new UCLA-led study show that the pandemic has exacerbated disparities in care, widening inequities.

The study also found conflicting feelings, as participants seemed overwhelmed by too many recommendations while simultaneously perceiving cancer as an unavoidable death sentence.

Wright said that there would be 1 drug that could inhibit the reactivation of all 9 of the herpesviruses.

Suzanne Soliman, PharmD, BCMAS, discussed alcohol abuse and when the pharmacist becomes the patient with Sherry Price, PharmD, MBA, APh, BCPS, pharmacist and creator of the Drink Less Lifestyle podcast and program.

Anna Legreid Dopp, PharmD, the Senior Director of Clinical Guidelines & Quality Improvement at ASHP, and Bayli Larson, PharmD, the Strategic Initiatives Associate at ASHP, discuss the grant the ASHP received from the American Rescue Plan.

The FDA has approved atogepant oral tablets (Qulipta; AbbVie) for the preventive treatment of episodic migraines in adults.

Previous studies provided proof of concept that peanut oral immunotherapy could be given safely to young children and have a therapeutic effect.

Umbralisib (Ukoniq) is indicated for the treatment of adult patients with relapsed or refractory marginal zone lymphoma and relapsed or refractory follicular lymphoma.

Symptoms of depression were reduced as quickly as 1 to 4 hours after a single treatment and lasted up to 2 weeks.

Abemaciclib (Verzenio) was recently approved in combination with endocrine therapy for the adjuvant treatment of adult patients with HR–positive, HER2-negative, node-positive, early breast cancer at high risk of recurrence.

Gout is characterized by sudden, severe attacks of pain, swelling, redness, and tenderness in one or more joints, most often in the big toe.

Mental Health Parity and Addiction Equity Act disallows insurers offering lower-quality benefits for behavioral health treatments.

Ron Lanton III, Esq, principal at Lanton Law, said entrepreneur Mark Cuban's new venture into the pharmacy field is very interesting, although it maybe just another player in the mail-order pharmacy market.

Interventions to improve medication adherence may have a greater impact on individual patients and the population as a whole than any novel treatment or therapy.

But study results show some are not sold on performing the task; adequate training can build their confidence.

The study will have 3 cohorts examining different regimens of the current Pfizer-BioNTech COVID-19 vaccine or an omicron-based vaccine and will use participants from the phase 3 COVID-19 booster study.

The findings suggest that pregnant women should not delay COVID-19 vaccination until late pregnancy.

The analysis of 204 countries and territories reveals that AMR is now a leading cause of death worldwide, which is higher than HIV/AIDS or malaria.

Women had lower health-related quality of life at the beginning of the study, although men experienced a more rapid decline over time.

Shreejit Nair, senior vice president and life sciences market business lead at CitiusTech, discusses some trends and predictions for health care IT this year and on into the future.

Brian Thornley, the Associate Vice President of Supply Excellence, Innovation and Digital Strategy at Merck, discusses what makes blockchain unique and what it could mean down the road for pharmacies.

This month's OTC Cases focus on influenza.

Mitchel Rothholz, RPh, MBA, chief of governance and state affiliates at the American Pharmacists Association (APhA) and executive director of the APhA Foundation, discusses the results of a nationwide survey of pharmacists during the ongoing pandemic.

Probiotic Pearls Women’s helps support digestive and immune health.

Linaclotide (Linzess) is indicated for irritable bowel syndrome with constipation and chronic idiopathic constipation.